Partner with the World’s Leading Forum for Diagnostics Stakeholders
Backed by 15 years of scientific knowledge exchange and hyper-aligned networking, the 16th World Clinical Biomarkers & Companion Diagnostics Summit is the industry's most established biomarker and drug-diagnostic forum, fueling the latest precision medicine strides across oncology, neurological, autoimmune, and rare disease indications.
Serving as the precision medicine community's global annual touchpoint, this year's meeting will unite 600+ biopharma, testing labs, diagnostic development, regulation, and reimbursement leaders, offering a high-impact platform to connect, partner, and grow the industry's visibility of your services.
If you have relevant services and would like to align your company within the precision medicine community, contact us to promote your brand through a bespoke commercial package. Email sponsor@hansonwade.com to request more information.
What to Expect?
Meet New Clients
Expand your client base within the global precision medicine community by networking face-to-face with dedicated senior attendees actively seeking solutions to overcome their biomarker and drug-diagnostic challenges.
Centre Yourself in Biopharma Dealmaking
Position your brand in front of C-Level decision-makers by showcasing your company logo on event materials including our website, brochure, and on-site signage.
Demonstrate Your Expertise
Present your work within one of our focused tracks, participate in a panel discussion or showcase your solutions in a bespoke exhibition booth to demonstrate your company's unique capabilities.
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from KOLs. Gain insights and competitor strategies to shape your organization’s future and sharpen its competitive edge.
Key Services & Solutions
Our industry attendees are looking for service and solution providers with capabilities in the below areas but not limited to:
Advancing compliant companion diagnostics solutions from bench to bedside
Improving patient selection and monitoring with liquid biopsy platforms
Identifying clinically meaningful biomarkers with novel biomarker assay development and validation
Bolstering accessible and scalable diagnostic testing through clinical laboratories
Accelerating towards harmonized drug-diagnostic approvals with IVD compliance and regulatory adherence
Enhancing data-driven strategies with AI-enabled biomarker discovery and clinical decision support
Audience Composition
Company Type*
Attendee Seniority*
*Statistics from 14th World Clinical Biomarkers & CDx Summit
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Sam Sarwar
Senior Commercial Director